Chronic Hepatitis News

All patients who completed direct-acting antiviral therapy after orthotopic heart transplantation with hepatitis C-positive donor hearts achieved sustained virologic, according to results from a recent study.

AbbVie announced an agreement with the pan-Canadian Pharmaceutical Alliance in which Ontario will be first province to reimburse the hepatitis C direct-acting antiviral Maviret on its public formulary as of February 28, 2019, according to a press release.

Researchers determined a target limit of detection for hepatitis C point-of-care tests that would identify 97% of viremic infections among all populations including low- and middle-income countries, according to a recently published study.

Abbott received CE Mark for the company’s Determine HBsAg 2 test, a rapid diagnostic test designed to detect hepatitis B surface antigen, according to a press release.

The CDC recently announced that all persons aged 1 year or older experiencing homelessness should be routinely immunized for hepatitis A, based on a review of recent data.

Results of a prospective study showed that treatment with direct-acting antivirals for hepatitis C correlated with significantly reduced risks for hepatocellular carcinoma and mortality, according to a study published in The Lancet.

Among patients with chronic hepatitis B, the cumulative incidence of severe alanine aminotransferase flares was low and correlated with decreased HBV DNA levels and loss of HBV e-antigen, according to recently published data.

As researchers continue to focus on hard-to-reach populations for hepatitis C testing and treatment, the ongoing opioid epidemic presents an opportunity for prevention as treatment through outreach and education in the regions with highest injection drug use.

Low levels of free testosterone are common among men with chronic hepatitis C infection following SVR and persist after HCV clearance, according to findings from a prospective, longitudinal cohort study.

More than two-thirds of patients with hepatitis C who visited a Federally Qualified Health Center in Philadelphia were linked to care, including both antibody and RNA testing, and many continued to medical evaluation, according to a study published in Hepatology.